Michael H. Thaman - 08 Jun 2026 Form 4 Insider Report for UL Solutions Inc. (ULS)

Reporting relationship: Director
Issuer ticker: ULS
Reported as of: 08 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 17:27:20 UTC
Prior SEC filing: 22 May 2026
Next SEC filing: 08 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Ryan Robinson, Attorney-in-Fact

Key filing fact

Michael H. Thaman filed Form 4 for UL Solutions Inc. (ULS) on 10 Jun 2026.

Key facts

This page summarizes Michael H. Thaman's Form 4 filing for UL Solutions Inc. (ULS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 17:27.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001228309 Primary reporting owner

THAMAN MICHAEL H

Relationship: Director
Address: C/O UL SOLUTIONS INC., 333 PFINGSTEN ROAD, NORTHBROOK
Signature: /s/ Ryan Robinson, Attorney-in-Fact
Signature date: 10 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ULS transaction Derivative

Deferred Restricted Stock Units

Award

Transaction value
Shares: +3
Change %: +0.14%
Price: $0.000000^*
Shares after: 2,209
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 3
Exercise price
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Footnote F2

Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person.

Footnote F3

The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.

Footnote F4

Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date.